A Medication Abortion Drug Faces Potential Nationwide Restriction
A federal court case underway in Texas this week could have big implications for medication based abortion care across the U.S. The case involves the FDA’s approval of the drug mifepristone, which is used as part of a two-drug combination in most medication abortions.
The plaintiffs in the case are arguing that the FDA went against its own guidelines regarding drug safety when it approved the medication in 2000, though the overwhelming evidence has shown the drug to be safe and effective. A ruling against the FDA could result in mifepristone prescriptions being banned nationwide.
Maggie Koerth, senior science writer at FiveThirtyEight, joins John Dankosky to talk about the case and its implications. They also tackle other stories from the week in science, including investigations of the Earth’s inner core, a timeline for astronauts on board the ISS, and efforts to understand what “burnout” actually is.
Invest in quality science journalism by making a donation to Science Friday.
Maggie Koerth is a science journalist based in Minneapolis, Minnesota.
The transcript is being processed. It will be available the week after the segment airs.
John Dankosky works with the radio team to create our weekly show, and is helping to build our State of Science Reporting Network. He’s also been a long-time guest host on Science Friday. He and his wife have three cats, thousands of bees, and a yoga studio in the sleepy Northwest hills of Connecticut.